웹2024년 4월 17일 · Bain Capital agreed to invest about $816 million in Hugel Inc. to gain control of the South Korea-based maker of beauty products, including botox. Hugel shares … 웹2024년 11월 11일 · The lender will also issue 45,357,385 warrants convertible into equity shares at a price of Rs 565 apiece. The bank said this would involve a dilution of 8.23 per cent stake for the existing shareholders. According to Axis Bank, entities affiliated to Bain Capital propose to invest Rs 6,854 crore. LIC, an existing investor in the bank, plans to ...
Hugel:One step closer to becoming a global player
웹2024년 8월 25일 · Bain Capital has sold its 42.9-percent stake plus convertible bonds in Kosdaq-listed Hugel, Korea's largest manufacturer of botulinum toxin. The buyer is a consortium owned by CBC Group, a Singapore private equity company, Abu Dhabi-based Mubadala Investment, and an unnamed special purpose company, which is owned equally … 웹2024년 8월 25일 · Bain Capital has sold its controlling stake in South Korea’s leading Botox maker to a consortium of investors for $1.5bn as the Covid-19 pandemic fuels a surge in demand for cosmetic surgery in the country. Seoul-based Hugel, founded in 2001, is South Korea’s biggest producer of botulinum toxin. It also makes dermal facial fillers, which ... bush brothers and company stock price
Bain Makes $816 Million Botox Bet in Deal for Hugel Control (1)
웹2024년 6월 6일 · 6 June 2024. Bain Capital Private Equity has acquired a controlling stake in South Korean biopharmaceutical company Hugel for KRW 927.5 billion ($831 million; €736 … 웹2024년 1월 7일 · When Bain Capital announced that it would become the largest shareholder of the biotech firm by investing US$816 million to acquire a 40 percent stake last year, its stock price had soared. At the time of the acquisition in July, it hit 491,000 won, however, dropped to 274,400 won in November. Hugel’s share price closed at 349,500 won on Jan. 4. 웹2024년 4월 18일 · Global private equity fund (PEF) giant Bain Capital has agreed to buy nearly half of stakes in South Korean biopharmaceutical firm Hugel Inc. at 927.2 billion won ($817 million) to become the Korean company’s largest stakeholder. Hugel said on Monday that its shareholders voted in favor of issuing new shares and convertible bonds worth … handguard length for 14.5 barrel